They note that effective coordination among oncologists, pharmacists, and other providers is vital to ensure safe and ...

Panelists highlight barriers in community practice that limit third-line therapy uptake, including lack of familiarity with ...

Kavita Nair, PhD, FAAN, discusses academic medical centers' unique role in diagnosing and managing neurodegenerative diseases ...

Her study, "Medicare Advantage Reimbursement Structures Impact Home Health Delivery and Outcomes," explores how home health ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet ...

Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...

Women under age 50 who consume higher amounts of ultraprocessed foods (UPFs) face significantly increased odds of developing ...

Clark Alsfeld, MD, discusses how telemedicine, pharmacists, and evolving policies help overcome financial and geographic ...

Patients seeking access to oral acute myeloid leukemia (AML) medications face complex insurance approval processes that can ...

Panelists discuss how managing oral therapy toxicities requires preemptive planning, multidisciplinary team involvement, ...

Panelists discuss how prescription digital therapeutics like Daylight show promise for treating depression and anxiety but ...

Panelists discuss how digital therapeutics could address the enormous unmet need for treating negative symptoms in the 60% of ...